Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

5160 of over 100 results
Beyfortus (nirsevimab) Now Available Through VFC
2024 · Philadelphia Department of Public Health
This announcement explains that providers can order nirsevimab (Beyfortus) through Vaccines for Children (VFC). It covers the following areas of consideration: dosage and administration, eligible …
5 Tips on Buying Beyfortus (nirsevimab-alip) for Babies
2024 · PracticeWell
This webpage explains how to order Beyfortus, a monoclonal antibody that may prevent young infants from getting respiratory syncytial virus (RSV). It covers discounts, reimbursements, …
Nirsevimab Monoclonal Antibody Memo (2024-2025)
2024 · Lucile Packard Children's Hospital Stanford
This memo outlines recommendations and an implementation plan for nirsevimab (Beyfortus™), a long-acting monoclonal antibody effective against respiratory syncytial virus (RSV), at Lucile Packard Children’s …
Impact of Nirsevimab on Admission to a Spanish Pediatric Intensive Care Unit Because of RSV Bronchiolitis: Unicentric Observational Study from 2017 to 2024
2024 · Hospital Infantil Universitario Niño Jesús
This letter describes admissions to a pediatric critical care unit (PICU) because of acute bronchiolitis caused by respiratory syncytial virus. The study looked at a …
Beyfortus® For Prevention of Respiratory Syncytial Virus (RSV) in Infants
2024 · Nationwide Children's Hospital
This webpage provides a pharmacy update on the use of Beyfortus for the prevention of RSV in infants. The FDA approved nirsevimab for infants and …
Guidelines for Inpatient Administration of Nirsevimab to Infants and Children
2024 · University of Michigan
This 4-page document explain how to give nirsevimab to infants and children in hospitals. It describes dosing based on age and weight, especially after heart …
Pharmacy Podcast Episode 162: Nirsevimab: Prevent RSV or Let it Be?
2024 · Mayo Clinic
This podcast discusses nirsevimab and its role in preventing respiratory syncytial virus (RSV) in infants. Kimberly James, PharmD discusses which patients could benefit from nirsevimab, …
Vaccine Resources: Nirsevimab Effectiveness, AI in Health Communication and Updated VISs
2024 · Children's Hospital of Philadelphia
This post is about vaccine resources, focusing on the effectiveness of nirsevimab, a medication used to prevent respiratory infections in infants. It describes how artificial …
RSV Prevention Within Reach for Older Infants and Toddlers: The Role of Active Immunization
2024 · St. Jude Children's Research Hospital, · University of Tennessee
This article reviews efforts to prevent RSV in older infants and toddlers through active immunization. It highlights the global impact of RSV, especially in young …
Preventing Respiratory Syncytial Virus in Infants
2024 · University of Alberta, · The College of Family Physicians of Canada
This one-page article outlines how monoclonal antibodies can help prevent respiratory syncytial virus (RSV) in infants. Palivizumab, given in 4 to 5 doses during RSV …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie
5160 of over 100 results